Clinical Trial Update: Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of haploidentical donor hematopoietic progenitor cell and natural killer (NK) cell transplantation for hematologic malignancies has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Drugs mentioned

• haploidentical donor hematopoietic progenitor cell and NK cell transplantation

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2022-10-31